As with climate change, why are we so slow to recognise the existential threat that drug use poses to humanity?
The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...
In a new superseding indictment filed Thursday, prosecutors expanded their sex trafficking and racketeering case against Sean ...
It’s time for Virginia legislators to pay more than lip service to social media protections for kids
Virginia legislators shelve another bill aimed at protecting kids on social media. It's time they stood up to the tech titans ...
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
Vertex Pharma has secured FDA approval for its non-opioid pain drug suzetrigine, becoming the first new class of pain ...
THE TV – “Feel tired? Out of energy? Then you need Oxyoxt.” “I used to have broken bones, cancer of the thumbs and nightmares ...
Under the racketeering count, which is now backdated to 2004 from the original indictment’s 2008, prosecutors accuse Combs and his associates of dealing numerous controlled substances, including ...
Vertex Pharmaceuticals’ non-opioid pain medication is up for FDA approval this week. Other drugmakers have found safer ...
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.
Rexulti (brexpiprazole) has potential interactions with alcohol and other medications. For example, Rexulti can interact with other antipsychotics, such as risperidone (Risperdal). An interaction ...
Patients and Methods: A randomised, open-label, multicentre, crossover study was conducted in 178 patients requiring treatment for cancer pain, of which 134 were included in the tolerability ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback